Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder.

Lydiard RB, Morton WA, Emmanuel NP, Zealberg JJ, Laraia MT, Stuart GW, O'Neil PM, Ballenger JC.

Psychopharmacol Bull. 1993;29(2):183-8.

PMID:
8290663
2.

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.

Sasson Y, Iancu I, Fux M, Taub M, Dannon PN, Zohar J.

Eur Neuropsychopharmacol. 1999 Mar;9(3):191-6.

PMID:
10208287
3.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Review. French.

PMID:
18922243
4.

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.

Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.

J Clin Psychiatry. 1998 Oct;59(10):528-34.

PMID:
9818634
5.
6.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
7.

Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.

Bloch M, Schwartzman Y, Bonne O, Lerer B.

J Clin Psychopharmacol. 1997 Feb;17(1):44-8.

PMID:
9004056
8.

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

Sheehan DV, Burnham DB, Iyengar MK, Perera P; Paxil CR Panic Disorder Study Group..

J Clin Psychiatry. 2005 Jan;66(1):34-40.

PMID:
15669886
9.

Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.

Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.

J Clin Psychopharmacol. 1987 Oct;7(5):295-310.

PMID:
3316312
10.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005.

PMID:
19042026
11.

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.

Pollack MH, Rapaport MH, Fayyad R, Otto MW, Nierenberg AA, Clary CM.

J Psychiatr Res. 2002 Jul-Aug;36(4):229-36.

PMID:
12191627
12.

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.

Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW.

Psychiatry Res. 2001 Aug 5;103(1):1-14.

PMID:
11472786
13.

Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.

Bakker A, van Dyck R, Spinhoven P, van Balkom AJ.

J Clin Psychiatry. 1999 Dec;60(12):831-8.

PMID:
10665629
14.

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.

Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.

J Clin Psychopharmacol. 1992 Apr;12(2):96-103.

PMID:
1573046
15.

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.

Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.

J Clin Psychopharmacol. 2000 Oct;20(5):556-9.

PMID:
11001241
16.

Adinazolam sustained-release treatment of panic disorder: a double-blind study.

Davidson JR, Beitman B, Greist JH, Maddock RJ, Lewis CP, Sheridan AQ, Carter C, Krishnan KR, Liebowitz MR, Haack DG.

J Clin Psychopharmacol. 1994 Aug;14(4):255-63.

PMID:
7962681
17.

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

Stahl SM, Gergel I, Li D.

J Clin Psychiatry. 2003 Nov;64(11):1322-7.

PMID:
14658946
18.

Desipramine treatment in panic disorder.

Kalus O, Asnis GM, Rubinson E, Kahn R, Friedman JM, Iqbal N, Grosz D, van Praag H, Cahn W.

J Affect Disord. 1991 Apr;21(4):239-44.

PMID:
1829745
19.

Sertraline treatment of panic disorder: response in patients at risk for poor outcome.

Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychiatry. 2000 Dec;61(12):922-7.

PMID:
11206597
20.
Items per page

Supplemental Content

Support Center